Follitropin Alpha
Ovulation Induction
Merck KGaA, Darmstadt, GermanyPhase 4 / ApprovedDormant
A
81/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 71/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Ovulation Induction cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CLOMIPHENE CITRATE University Hospital, Ghent | Phase 4 | BB |
Inositol University Hospital, Ghent | Phase 4 | BB |
Folic Acid University Hospital, Ghent | Phase 4 | BB |
FOLLITROPIN BETA Merck KGaA, Darmstadt, Germany | Phase 3 | BB |
Urofollitropin Merck KGaA, Darmstadt, Germany | Phase 3 | BB |
View all 10 →
Same molecule, other indications
Follitropin Alpha is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →